Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin options worth $1.47B expired with max pain at $83K, signaling cautious market sentiment.

Market News
16 Oct 2026
Tokenpost
View Source
Neutral
Bitcoin options worth $1.47B expired with max pain at $83K, signaling cautious market sentiment.

Bitcoin options contracts valued at $1.47 billion expired on October 16, 2026, with about 18,000 contracts expiring, representing 4.5% of open interest. The max pain price was $83,000, indicating the price level where option holders would face the greatest losses. The put/call ratio was balanced at 1, and implied volatility was low at around 35%, showing that traders expect minimal price fluctuations in the near future. This suggests a cautious stance among options buyers in the Bitcoin market.

Bitcoin options expiration data provides context for cryptocurrency market activity. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Oct 17, 2026 00:22 WIB: out of 50 major cryptocurrencies, 16 rose and 33 fell today. CAKE declined by 4.41% to Rp38.237 with nearly balanced Pluang order activity (49% Sell / 51% Buy), while XNO gained 4.01% to Rp6.068 despite a majority sell order activity (60% Sell / 40% Buy). DOT rose 3.79% to Rp20.559 with strong buy interest (4% Sell / 96% Buy) and the longest typical hold time of 121 days among these movers.

More News

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...

Market News
Bullish
52 minutes ago
BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...

Market News
Neutral
1 hour ago
FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...

Market News
Bullish
1 hour ago
K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...

Market News
Bullish
1 hour ago
BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock, Inc. disclosed that its shareholding in Fagron NV dropped below the 3% threshold to 2.96% after selling some voting securities, despite acquiring equivalent financial instruments. As of October 12, 2026, BlackRock holds 2,015,779 voting ri...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App